Total Payments
$183.50
2024 Payments
$94.43
Companies
8
Transactions
11
Medicare Patients
5,534
Medicare Billing
$170,961
Payment Breakdown by Category
Food & Beverage$183.50 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $183.50 | 11 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | $48.18 | 3 | $0 (2024) |
| PFIZER INC. | $31.36 | 2 | $0 (2024) |
| Merck Sharp & Dohme LLC | $26.12 | 1 | $0 (2024) |
| Phathom Pharmaceuticals, Inc. | $19.11 | 1 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $18.41 | 1 | $0 (2021) |
| Novo Nordisk Inc | $16.86 | 1 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $12.25 | 1 | $0 (2021) |
| Nestle HealthCare Nutrition Inc. | $11.21 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $94.43 | 5 | Merck Sharp & Dohme LLC ($26.12) |
| 2023 | $47.20 | 3 | Bayer Healthcare Pharmaceuticals Inc. ($32.08) |
| 2021 | $41.87 | 3 | Janssen Pharmaceuticals, Inc ($18.41) |
All Payment Transactions
11 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/06/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $19.11 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/23/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $16.24 | General |
| Category: PAIN | ||||||
| 04/08/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug) | Food and Beverage | In-kind items and services | $26.12 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 04/02/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.10 | General |
| Category: Cardio-renal | ||||||
| 03/27/2024 | Novo Nordisk Inc | Wegovy (Drug), Saxenda | Food and Beverage | In-kind items and services | $16.86 | General |
| Category: Obesity | ||||||
| 09/18/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: Cardio-renal | ||||||
| 05/02/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.10 | General |
| Category: Cardio-renal | ||||||
| 04/07/2023 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: PAIN | ||||||
| 10/06/2021 | Nestle HealthCare Nutrition Inc. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $11.21 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 06/16/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.41 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/07/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.25 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 27 | 2,491 | 5,083 | $288,773 | $78,204 |
| 2022 | 24 | 2,218 | 4,660 | $251,538 | $63,178 |
| 2021 | 14 | 645 | 1,127 | $62,002 | $18,699 |
| 2020 | 3 | 180 | 208 | $22,792 | $10,879 |
Total Patients
5,534
Total Services
11,078
Medicare Billing
$170,961
Procedure Codes
68
All Medicare Procedures & Services
68 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 399 | 551 | $84,854 | $26,081 | 30.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 180 | 210 | $47,174 | $14,444 | 30.6% |
| 87502 | Detection test by nucleic acid for multiple types influenza virus | Office | 2023 | 99 | 107 | $16,050 | $9,623 | 60.0% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 115 | 128 | $18,813 | $9,116 | 48.5% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2023 | 104 | 111 | $16,650 | $5,289 | 31.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 367 | 534 | $29,354 | $3,946 | 13.4% |
| 83880 | Natriuretic peptide (heart and blood vessel protein) level | Office | 2023 | 30 | 34 | $3,230 | $1,308 | 40.5% |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 2023 | 184 | 231 | $6,930 | $1,058 | 15.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 14 | 14 | $4,854 | $990.55 | 20.4% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 112 | 131 | $3,275 | $989.30 | 30.2% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 21 | 21 | $1,932 | $727.02 | 37.6% |
| J2010 | Injection, lincomycin hcl, up to 300 mg | Office | 2023 | 86 | 97 | $1,940 | $665.61 | 34.3% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 47 | 48 | $2,111 | $644.52 | 30.5% |
| 87651 | Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique | Office | 2023 | 14 | 14 | $980.00 | $481.46 | 49.1% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 28 | 30 | $1,050 | $473.72 | 45.1% |
| 80047 | Blood test, basic group of blood chemicals (calcium, ionized) | Office | 2023 | 32 | 32 | $755.52 | $430.72 | 57.0% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2023 | 235 | 1,204 | $25,284 | $419.21 | 1.7% |
| 81003 | Automated urinalysis test | Office | 2023 | 119 | 148 | $927.96 | $324.24 | 34.9% |
| J1020 | Injection, methylprednisolone acetate, 20 mg | Office | 2023 | 17 | 54 | $1,350 | $212.09 | 15.7% |
| 85379 | Coagulation function measurement, d-dimer; quantitative | Office | 2023 | 20 | 20 | $600.00 | $199.60 | 33.3% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 20 | 22 | $550.00 | $182.38 | 33.2% |
| 73620 | X-ray of foot, 2 views | Office | 2023 | 14 | 14 | $636.02 | $169.68 | 26.7% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 13 | 13 | $455.00 | $134.55 | 29.6% |
| 74018 | X-ray of abdomen, 1 view | Office | 2023 | 11 | 11 | $379.17 | $118.93 | 31.4% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 154 | 1,139 | $13,668 | $94.30 | 0.7% |
About Brooke Scallion, FNP-C
Brooke Scallion, FNP-C is a Emergency Medicine healthcare provider based in Indianola, Mississippi. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/25/2017. The National Provider Identifier (NPI) number assigned to this provider is 1609385392.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Brooke Scallion, FNP-C has received a total of $183.50 in payments from pharmaceutical and medical device companies, with $94.43 received in 2024. These payments were reported across 11 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($183.50).
As a Medicare-enrolled provider, Scallion has provided services to 5,534 Medicare beneficiaries, totaling 11,078 services with total Medicare billing of $170,961. Data is available for 4 years (2020–2023), covering 68 distinct procedure/service records.
Ad
Practice Information
- Specialty Emergency Medicine
- Other Specialties Family Medicine
- Location Indianola, MS
- Active Since 09/25/2017
- Last Updated 09/25/2017
- Taxonomy Code 207P00000X
- Entity Type Individual
- NPI Number 1609385392
Products in Payments
- Kerendia (Drug) $48.18
- NURTEC ODT (Drug) $31.36
- DIFICID (Drug) $26.12
- VOQUEZNA (Drug) $19.11
- XARELTO (Drug) $18.41
- Wegovy (Drug) $16.86
- FARXIGA (Drug) $12.25
- ZENPEP (Drug) $11.21
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.